Pages that link to "Q59678759"
Jump to navigation
Jump to search
The following pages link to Alan Lyons (Q59678759):
Displaying 50 items.
- Modulation of lymphocyte migration to the murine spleen after marginal zone macrophage phagocytosis of blood-borne particulate material (Q24307653) (← links)
- B cell differentiation and isotype switching is related to division cycle number (Q24677647) (← links)
- Immunology of a Transmissible Cancer Spreading among Tasmanian Devils (Q28082825) (← links)
- Determination of lymphocyte division by flow cytometry (Q28253058) (← links)
- Flow cytometric analysis of cell division by dye dilution (Q28292945) (← links)
- Acquisition of immune function during the development of the Langerhans cell network in neonatal mice (Q28366015) (← links)
- Simultaneous analysis of immunophenotype and apoptosis of murine thymocytes by single laser flow cytometry (Q30745644) (← links)
- Divided we stand: tracking cell proliferation with carboxyfluorescein diacetate succinimidyl ester (Q33778838) (← links)
- Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. (Q34032209) (← links)
- Natural killer cell mediated cytotoxic responses in the Tasmanian devil (Q34034657) (← links)
- Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils (Q34552989) (← links)
- Flow cytometric analysis of cell division by dilution of CFSE and related dyes (Q34644480) (← links)
- The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines (Q36218717) (← links)
- The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. (Q36366646) (← links)
- A second transmissible cancer in Tasmanian devils (Q36483243) (← links)
- Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils. (Q37393209) (← links)
- PD-L1 Is Not Constitutively Expressed on Tasmanian Devil Facial Tumor Cells but Is Strongly Upregulated in Response to IFN-γ and Can Be Expressed in the Tumor Microenvironment (Q37486606) (← links)
- The toll-like receptor ligands Hiltonol® (polyICLC) and imiquimod effectively activate antigen-specific immune responses in Tasmanian devils (Sarcophilus harrisii). (Q38660758) (← links)
- Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations (Q38906804) (← links)
- Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil (Q38984004) (← links)
- Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease. (Q39313794) (← links)
- The absence of TNF permits myeloid Arginase 1 expression in experimental L. monocytogenes infection (Q40198180) (← links)
- An isolate of Haemophilus haemolyticus produces a bacteriocin-like substance that inhibits the growth of nontypeable Haemophilus influenzae. (Q40315622) (← links)
- Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. (Q40473904) (← links)
- The importance of efficacy and partial agonism in evaluating models of B lymphocyte activation. (Q41493246) (← links)
- Specific binding of human interleukin-3 and granulocyte-macrophage colony-stimulating factor to human basophils (Q41811703) (← links)
- Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors (Q44582801) (← links)
- Imatinib inhibits the functional capacity of cultured human monocytes. (Q45231421) (← links)
- Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo (Q46214331) (← links)
- Inhibition of c-fms by imatinib: expanding the spectrum of treatment. (Q46510966) (← links)
- In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML. (Q46547149) (← links)
- Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells (Q46561991) (← links)
- Dasatinib suppresses in vitro natural killer cell cytotoxicity (Q46656778) (← links)
- The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro (Q46658958) (← links)
- Snapper (Pagrus auratus) leucocyte proliferation is synergistically enhanced by simultaneous stimulation with LPS and PHA. (Q47659561) (← links)
- Drug-interaction studies evaluating T-cell proliferation reveal distinct activity of dasatinib and imatinib in combination with cyclosporine A. (Q47874171) (← links)
- Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. (Q49101398) (← links)
- Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with Leishmania major (Q49219150) (← links)
- Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease. (Q52558324) (← links)
- Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells. (Q52584367) (← links)
- Maternal exposure to particulate matter alters early post-natal lung function and immune cell development. (Q52600709) (← links)
- Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release. (Q52668327) (← links)
- Human myeloid differentiation antigens identified by monoclonal antibodies to the myelomonocytic leukemia cell line RC-2A. (Q53415291) (← links)
- Human Flt-3 ligand-mobilized dendritic cells require additional activation to drive effective immune responses (Q56797374) (← links)
- Assessment of snapper (Pagrus auratus) natural IgM binding to bromelain treated sheep erythrocytes (Q56797381) (← links)
- A monoclonal antibody to a human mast cell/myeloid leukaemia-specific antigen binds to normal haemopoietic progenitor cells and inhibits colony formation in vitro (Q67232535) (← links)
- Human interleukin-3 inhibits the binding of granulocyte-macrophage colony-stimulating factor and interleukin-5 to basophils and strongly enhances their functional activity (Q67672707) (← links)
- Discrete subpopulations, defined by CD45 isoforms, coexist within the leukaemic cells of B-chronic lymphocytic leukaemia patients (Q67903355) (← links)
- The effect of recombinant cytokines on the proliferative potential and phenotype of cells of the human myelomonocytic leukaemia line, RC-2A (Q67958942) (← links)
- Studies on the differentiation of the human myelomonocytic cell line RC-2A in response to lymphocyte-derived factors (Q68197084) (← links)